Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lamictal in pediatric subjects with partial seizures (1-24 months)
NCT00044278Phase 2Completed
- Sponsor
- GSK
- Start
- Sep 2000
- Primary completion
- Jun 2006
- Modality
- Small Molecules
- Countries
- 15
01
Overview
Phase 2, open-label, single-arm trial of lamotrigine in epilepsy, sponsored by GSK. Primary endpoints: Adverse Events at 43 months, Heart Rate at 43 months and 3 more. Started Sep 2000; status: completed.
02
Drugs
lamotrigine
03
Conditions
epilepsy
Beyond the preview
Go deeper on NCT00044278.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00044278.